Healthcare provider profile · identity verified

Tyler J Baker, MD

Family Practice · SPOKANE, WA · NPI 1972764074

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	726	200
Losartan Potassium	Losartan Potassium	383	111
Levothyroxine Sodium	Levothyroxine Sodium	299	73
Lisinopril	Lisinopril	286	79
Amlodipine Besylate	Amlodipine Besylate	276	78
Hydrochlorothiazide	Hydrochlorothiazide	238	69
Omeprazole	Omeprazole	214	74
Tamsulosin Hcl	Tamsulosin Hcl	209	68
Rosuvastatin Calcium	Rosuvastatin Calcium	177	52
Metoprolol Succinate	Metoprolol Succinate	153	48
Potassium Chloride	Potassium Chloride	147	54
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	142	31
Furosemide	Furosemide	123	47
Metformin Hcl	Metformin Hcl	120	36
Metformin Hcl Er	Metformin Hcl	107	34
Gabapentin	Gabapentin	105	35
Trazodone Hcl	Trazodone Hcl	103	30
Pravastatin Sodium	Pravastatin Sodium	99	30
Allopurinol	Allopurinol	98	26
Ozempic	Semaglutide	98	20
Zolpidem Tartrate	Zolpidem Tartrate	98	31
Eliquis	Apixaban	92	20
Sertraline Hcl	Sertraline Hcl	90	30
Lorazepam	Lorazepam	87	25
Simvastatin	Simvastatin	85	21
Pantoprazole Sodium	Pantoprazole Sodium	83	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	76	21
Metoprolol Tartrate	Metoprolol Tartrate	74	20
Albuterol Sulfate Hfa	Albuterol Sulfate	71	30
Escitalopram Oxalate	Escitalopram Oxalate	68	20
Glipizide Er	Glipizide	67	19
Tramadol Hcl	Tramadol Hcl	64	16
Fluoxetine Hcl	Fluoxetine Hcl	60	17
Memantine Hcl	Memantine Hcl	60	14
Prednisone	Prednisone	60	24
Duloxetine Hcl	Duloxetine Hcl	58	19
Citalopram Hbr	Citalopram Hydrobromide	53	12
Bupropion Xl	Bupropion Hcl	52	15
Montelukast Sodium	Montelukast Sodium	51	13
Finasteride	Finasteride	49	20
Terazosin Hcl	Terazosin Hcl	49	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	48	12
Alendronate Sodium	Alendronate Sodium	46	14
Donepezil Hcl	Donepezil Hcl	46	12
Synthroid	Levothyroxine Sodium	46	13
Valacyclovir	Valacyclovir Hcl	45	22
Buspirone Hcl	Buspirone Hcl	44	12
Pregabalin	Pregabalin	43	11
Clopidogrel	Clopidogrel Bisulfate	42	16
Fluticasone Propionate	Fluticasone Propionate	42	18
Famotidine	Famotidine	41	12
Propranolol Hcl Er	Propranolol Hcl	41	11
Oxybutynin Chloride Er	Oxybutynin Chloride	36	11
Pioglitazone Hcl	Pioglitazone Hcl	36	13
Temazepam	Temazepam	36	suppressed
Atenolol	Atenolol	35	suppressed
Jardiance	Empagliflozin	35	14
Morphine Sulfate Er	Morphine Sulfate	35	suppressed
Ezetimibe	Ezetimibe	34	12
Triamcinolone Acetonide	Triamcinolone Acetonide	34	17
Carvedilol	Carvedilol	32	suppressed
Spironolactone	Spironolactone	31	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	30	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	29	suppressed
Estradiol	Estradiol	28	13
Nadolol	Nadolol	28	suppressed
Xarelto	Rivaroxaban	28	11
Trulicity	Dulaglutide	27	suppressed
Ondansetron Odt	Ondansetron	26	suppressed
Ipratropium Bromide	Ipratropium Bromide	25	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Felodipine Er	Felodipine	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Baclofen	Baclofen	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	16
Tizanidine Hcl	Tizanidine Hcl	22	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	12
Lovastatin	Lovastatin	21	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Ketoconazole	Ketoconazole	20	suppressed
Meloxicam	Meloxicam	20	suppressed
Celecoxib	Celecoxib	19	suppressed
Glipizide	Glipizide	19	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Divalproex Sodium	Divalproex Sodium	18	suppressed
Olanzapine	Olanzapine	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Fluconazole	Fluconazole	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Alprazolam	Alprazolam	15	suppressed
Clonazepam	Clonazepam	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	14	suppressed
Torsemide	Torsemide	14	suppressed
Aimovig Autoinjector	Erenumab-Aooe	13	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	13	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Fosinopril Sodium	Fosinopril Sodium	12	suppressed
Methylphenidate Er	Methylphenidate Hcl	12	suppressed
Victoza 3-Pak	Liraglutide	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Diazepam	Diazepam	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error